Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Myelin imaging with C-11 labeled diphenylmethanol and positron emission tomography

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6709214
The authors have recently studied several C-11-labeled radiopharmaceuticals for their suitability as myelin imaging agents with positron emission tomography (PET). C-11 diphenylmethanol (DPM) was selected on the basis of its in vivo metabolic stability and high extraction and lipophilicity. PET studies were performed in three normal subjects and in one patient with multiple sclerosis (MS). Myelin distribution was imaged following the bolus intravenous administration of 25-30 mCi of C-11 DPM. Sequential scans were obtained after radiotracer administration to measure the DPM distribution as a function of time. In addition, regional cerebral blood flow was measured after the bolus intravenous injection of 0-15 water. A tomographic slice through the centrum semiovale was used to obtain regional data for gray matter (GM) and white matter (WM).
Research Organization:
Washington Univ. School of Medicine, St. Louis, MO
OSTI ID:
6709214
Report Number(s):
CONF-850611-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 26:5
Country of Publication:
United States
Language:
English

Similar Records

Synthesis and biological studies of positron-emitting radiopharmaceuticals
Thesis/Dissertation · Fri Dec 31 23:00:00 EST 1982 · OSTI ID:5629027

C-11 dimethyloxazolidinedione (DMO): biodistribution, radiation absorbed dose, and potential for PET measurement of regional brain pH: concise communication
Journal Article · Thu Sep 01 00:00:00 EDT 1983 · J. Nucl. Med.; (United States) · OSTI ID:5640939

C-11 dimethyloxazolidinedione (DMO): biodistribution, radiation absorbed dose, and potential for PET measurement of regional brain pH: concise communication
Journal Article · Thu Sep 01 00:00:00 EDT 1983 · J. Nucl. Med.; (United States) · OSTI ID:5428652